Atlas Trials

Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study

Clinical trial NCT02057211 · TERMINATED

Trial details

NCT number
NCT02057211
Sponsor
Uppsala University Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2014-04-01
Primary completion
2017-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.